InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

TK

Tang, Kevin

OFFICER

US·SEC (Form 4)

Aurinia Pharmaceuticals Inc.

Cumul. flow

0

Total declarations

0

Company

€8m

▲ Purchases (10 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

10

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Tang, Kevin. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €7.7m. Activity tracked since 29 May 2026. The latest transaction was filed on 2 June 2026 (70 - Acquisition or disposition (writing) of third party derivative). Regulator: SEC (Form 4). All data is free.

Declarations15 total

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2026Aurinia Pharmaceuticals Inc.

CA$8,25023SEDI ↗

5,000 shares@ CA$1.650.0002% mcap0.1% of flowOptionsTSXSEDI:4728385

Ideal exit: 27 Feb 2027 (T+270)

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Sept 2024Aurinia Pharmaceuticals Inc.

OptionsTSXSEDI:4728383

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2026Aurinia Pharmaceuticals Inc.

CA$8,25023SEDI ↗

5,000 shares@ CA$1.650.0002% mcap0.1% of flowOptionsTSXSEDI:4728381

Ideal exit: 27 Feb 2027 (T+270)

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Sept 2024Aurinia Pharmaceuticals Inc.

OptionsTSXSEDI:4728241

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2026Aurinia Pharmaceuticals Inc.

CA$2M29SEDI ↗

103,002 shares@ CA$15.280.046% mcap12.6% of flowCommon SharesTSXSEDI:4728152

Ideal exit: 27 Feb 2027 (T+270)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jun 2026Aurinia Pharmaceuticals Inc.

CA$75221SEDI ↗

49 shares@ CA$15.340.0000% mcap0.0% of flowCommon SharesTSXSEDI:4728150

Ideal exit: 26 Feb 2027 (T+270)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jun 2026Aurinia Pharmaceuticals Inc.

CA$3M29SEDI ↗

171,760 shares@ CA$15.280.077% mcap21.1% of flowCommon SharesTSXSEDI:4728147

Ideal exit: 26 Feb 2027 (T+270)

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Sept 2024Aurinia Pharmaceuticals Inc.

Common SharesTSXSEDI:4728145

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2026Aurinia Pharmaceuticals Inc.

CA$2M29SEDI ↗

103,003 shares@ CA$15.280.046% mcap12.6% of flowCommon SharesTSXSEDI:4728143

Ideal exit: 27 Feb 2027 (T+270)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jun 2026Aurinia Pharmaceuticals Inc.

CA$76721SEDI ↗

50 shares@ CA$15.340.0000% mcap0.0% of flowCommon SharesTSXSEDI:4728142

Ideal exit: 26 Feb 2027 (T+270)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jun 2026Aurinia Pharmaceuticals Inc.

CA$3M29SEDI ↗

171,761 shares@ CA$15.280.077% mcap21.1% of flowCommon SharesTSXSEDI:4728141

Ideal exit: 26 Feb 2027 (T+270)

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 May 2026Aurinia Pharmaceuticals Inc.

50,000 sharesCommon SharesTSXSEDI:4728140

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 May 2026Aurinia Pharmaceuticals Inc.

50,000 sharesCommon SharesTSXSEDI:4728137

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 May 2026Aurinia Pharmaceuticals Inc.

CA$4M27SEDI ↗

262,682 shares@ CA$15.310.12% mcap32.3% of flowCommon SharesTSXSEDI:4728134

Ideal exit: 23 Feb 2027 (T+270)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 May 2026Aurinia Pharmaceuticals Inc.

CA$35,29017SEDI ↗

2,299 shares@ CA$15.350.0010% mcap0.3% of flowCommon SharesTSXSEDI:4728128

Ideal exit: 23 Feb 2027 (T+270)

15 of 15 declarations